Search research articles
Contact Us
Filters
Showing results (41-50 of 43) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 43 results.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
April 9, 2025
Psilocybin therapy for mood dysfunction in Parkinson's disease: an open-label pilot trial
Ellen R Bradley, Kimberly Sakai, Gisele Fernandes-Osterhold, et al.
Nature Medicine
|
May 11, 2021
MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study
Jennifer M Mitchell, Michael Bogenschutz, Alia Lilienstein, et al.
Focus (American Psychiatric Publishing)
|
July 5, 2023
MDMA-Assisted Therapy for Severe PTSD: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study
Jennifer M Mitchell, Michael Bogenschutz, Alia Lilienstein, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 43) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 43 results.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
April 9, 2025
Psilocybin therapy for mood dysfunction in Parkinson's disease: an open-label pilot trial
Ellen R Bradley, Kimberly Sakai, Gisele Fernandes-Osterhold, et al.
Nature Medicine
|
May 11, 2021
MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study
Jennifer M Mitchell, Michael Bogenschutz, Alia Lilienstein, et al.
Focus (American Psychiatric Publishing)
|
July 5, 2023
MDMA-Assisted Therapy for Severe PTSD: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study
Jennifer M Mitchell, Michael Bogenschutz, Alia Lilienstein, et al.
Page
of 5